ciprofloxacin has been researched along with 2,4-thiazolidinedione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuo-Rahma, GEA; Aziz, HA; Badr, M; El-Saghier, AMM; Shoman, ME | 1 |
1 other study(ies) available for ciprofloxacin and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Thiazolidine-2,4-dione-linked ciprofloxacin derivatives with broad-spectrum antibacterial, MRSA and topoisomerase inhibitory activities.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Thiazolidinediones; Thiazolidines; Topoisomerase II Inhibitors | 2022 |